Teva Pharmaceutical Industries Limited
TEVATeva Pharmaceutical Industries Ltd. (also known as Teva Pharmaceuticals) is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (APIs) and, to a lesser extent, contract manufacturing services and an out-licensing platform.
Drugs in Pipeline
102
Phase 3 Programs
60
Upcoming Catalysts
4
Next Catalyst
This month
Market Overview
Stock performance and key metrics
7 upcoming, 2 past
Fp/ABS Phase 3 Est. Readout
Primary completion for Fp/ABS trial (NCT06664619) in Asthma
Source6 more catalysts beyond 14 days
Start a 48-hour free trial to see all upcoming catalysts
How TEVA's past catalysts played out
rasagiline mesylate 1.0 mg
Parkinson's Disease
lipegfilgrastim
Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
Glatiramer Acetate (DB)
Multiple Sclerosis
Fp/ABS
Asthma
Laquinimod
Multiple Sclerosis
DR-102
Contraception
Fremanezumab
Migraine
Beclomethasone dipropionate
Seasonal Allergic Rhinitis
Diclofenac sodium
Actinic Keratosis
Glatiramer Acetate 20 mg/0.5 mL
Multiple Sclerosis
Glatiramer Acetate
Relapsing Remitting Multiple Sclerosis
FS MDPI
Asthma
Fp MDPI
Persistent Asthma
Estradiol
Dyspareunia
ACR16
Huntington Disease
Beclomethasone dipropionate BAI
Asthma
Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol
Rhinitis, Allergic, Perennial
Tapinarof Cream 1%
Plaque Type Psorisis
beclomethasone dipropionate (QVAR)
Asthma
Bendamustine hydrochloride
Non-Hodgkin Lymphoma
rasagiline mesylate
Multiple System Atrophy
GA 20 mg/mL
Relapsing-Remitting Multiple Sclerosis
Hydrocodone ER
Low Back Pain
Imiquimod Cream, 3.75%
Actinic Keratosis
Balugrastim
Chemotherapy-induced Neutropenia
Prednisone capsules
Perennial Allergic Rhinitis
Beclomethasone dipropionate breath-actuated inhaler
Persistent Asthma
TEV-50717
Cerebral Palsy, Dyskinetic
Glatiramer acetate (GA)
Relapsing Remitting Multiple Sclerosis
TV-46763
Pain
Glatiramer Acetate (GA) 40 mg
Relapsing Remitting Multiple Sclerosis
Budesonide/Formoterol SPIROMAX®
Asthma
Albuterol Sulfate
Asthma
Fluticasone Propionate/Salmeterol
Asthma
Albuterol
Asthma
Deutetrabenazine
Huntington Disease
Albuterol MDPI
Asthma
Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX
Asthma
Albuterol/salbutamol
Asthma
albuterol aerosol by HFA MDI
Exercise-induced Bronchospasm
Albuterol Spiromax
Exercise-Induced Bronchoconstriction (EIB)
Albuterol Spiromax®
Asthma
Albuterol sulfate (ABS)
Chronic Obstructive Pulmonary Disease
BDP
Allergic Rhinitis
TEV-56248
Asthma
1.0 mg rasagiline mesylate
Parkinson's Disease
Non-Oral Corticosteroid (non-OCS) Asthma Medication
Asthma
BDP HFA
Seasonal Allergic Rhinitis
Beclomethasone Dipropionate 640
Persistent Asthma
TV-44749
Schizophrenia
SD-809
Chorea
ProAir HFA inhaler
Asthma
BDP Nasal Aerosol
Allergic Rhinitis
DR-103
Pregnancy Prevention
DR-1021
Healthy
Trifarotene 0.005 % Topical Cream
Acne Vulgaris
Proventil® HFA
Asthma
Neugranin
Chemotherapy-induced Neutropenia
TV-46000
Schizophrenia
Reslizumab
Eosinophilic Asthma
40 mg glatiramer acetate
Amyotrophic Lateral Sclerosis
Nebulized IVX-0142
Asthma
Advair Diskus
Asthma
TP-38
Recurrent Glioblastoma Multiforme
laquinimod 0.3
Relapsing Remitting Multiple Sclerosis
Tizanidine (sublingual or oral)
Muscle Spasticity
etiprednol dicloacetate
Crohn's Disease
Beclomethasone dipropionate HFA
Asthma
Bronchodilator
Asthma
talampanel
Dyskinesias
TEV-53408
Celiac Disease
CEP-18770
Multiple Myeloma
Omacetaxine mepesuccinate
Chronic Myeloid Leukemia
TV-1380 150 mg
Cocaine Addiction
desogestrel/ethinyl estradiol and ethinyl estradiol
Hemostasis
Beclomethasone dipropionate HFA Nasal Aerosol
Seasonal Allergic Rhinitis
91-day Levonorgestrel Oral Contraceptive
Hemostasis
Mometasone furoate
Seasonal Allergic Rhinitis
TV-45070
Postherpetic Neuralgia
LBR-101 Low Dose
Episodic Migraine Headache
tbo-filgrastim
Neutropenia
TEV-48574
Crohn Disease
Albuterol HFA-BOI
Asthma
temozolomide(TMZ) 75mg
Glioblastoma Multiforme
TV-1106
Growth Hormone Deficiency
Delayed Release 6MP or Calcitriol vs. Purinethol
Crohn's Disease
glatiramer acetate 20 mg
Relapse-Remitting Multiple Sclerosis
Armodafinil
Stroke
Prednisolone/Prednisone
Lupus Nephritis
ProAir HFA
Asthma
glatiramer acetate 20 mg, with mitoxantrone
Relapsing Remitting Multiple Sclerosis
Glatiramer Acetate, N-Acetylcysteine
Relapse Remitting Multiple Sclerosis
TEV-56286
Multiple System Atrophy
ProAir® HFA
Asthma
Tiotropium HFA BAI 4.5 mcg
COPD
Rasagiline
Dementia
Flovent Diskus
Asthma
Immediate release morphine
Cancer
Deutetrabenazine 6 MG
Dystonia, Primary
LBR-101 High Dose
Chronic Migraine
glatiramer acetate with minocycline
Relapse Remitting Multiple Sclerosis
TEV-48574 Dose Regimen A
Crohn Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
rasagiline mesylate 1.0 mg | Phase 3 | Parkinson's Disease | - | Patent 2027 |
lipegfilgrastim | Phase 3 | Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia | - | - |
Glatiramer Acetate (DB) | Phase 3 | Multiple Sclerosis | - | - |
Fp/ABS | Phase 3 | Asthma | - | - |
Laquinimod | Phase 3 | Multiple Sclerosis | - | - |
DR-102 | Phase 3 | Contraception | - | - |
Fremanezumab | Phase 3 | Migraine | - | - |
Beclomethasone dipropionate | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Diclofenac sodium | Phase 3 | Actinic Keratosis | - | - |
Glatiramer Acetate 20 mg/0.5 mL | Phase 3 | Multiple Sclerosis | - | - |
Glatiramer Acetate | Phase 3 | Relapsing Remitting Multiple Sclerosis | - | - |
FS MDPI | Phase 3 | Asthma | - | - |
Fp MDPI | Phase 3 | Persistent Asthma | - | - |
Estradiol | Phase 3 | Dyspareunia | - | - |
ACR16 | Phase 3 | Huntington Disease | - | - |
Beclomethasone dipropionate BAI | Phase 3 | Asthma | - | - |
Beclomethasone dipropionate hydrofluoroalkane HFA Nasal Aerosol | Phase 3 | Rhinitis, Allergic, Perennial | - | - |
Tapinarof Cream 1% | Phase 3 | Plaque Type Psorisis | - | - |
beclomethasone dipropionate (QVAR) | Phase 3 | Asthma | - | - |
Bendamustine hydrochloride | Phase 3 | Non-Hodgkin Lymphoma | - | - |
rasagiline mesylate | Phase 3 | Multiple System Atrophy | - | - |
GA 20 mg/mL | Phase 3 | Relapsing-Remitting Multiple Sclerosis | - | - |
Hydrocodone ER | Phase 3 | Low Back Pain | - | - |
Imiquimod Cream, 3.75% | Phase 3 | Actinic Keratosis | - | - |
Balugrastim | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
Prednisone capsules | Phase 3 | Perennial Allergic Rhinitis | - | - |
Beclomethasone dipropionate breath-actuated inhaler | Phase 3 | Persistent Asthma | - | - |
TEV-50717 | Phase 3 | Cerebral Palsy, Dyskinetic | - | - |
Glatiramer acetate (GA) | Phase 3 | Relapsing Remitting Multiple Sclerosis | - | - |
TV-46763 | Phase 3 | Pain | - | - |
Glatiramer Acetate (GA) 40 mg | Phase 3 | Relapsing Remitting Multiple Sclerosis | - | - |
Budesonide/Formoterol SPIROMAX® | Phase 3 | Asthma | - | - |
Albuterol Sulfate | Phase 3 | Asthma | - | - |
Fluticasone Propionate/Salmeterol | Phase 3 | Asthma | - | - |
Albuterol | Phase 3 | Asthma | - | - |
Deutetrabenazine | Phase 3 | Huntington Disease | - | - |
Albuterol MDPI | Phase 3 | Asthma | - | - |
Budesonide and formoterol fumarate dehydrate (BF) SPIROMAX | Phase 3 | Asthma | - | - |
Albuterol/salbutamol | Phase 3 | Asthma | - | - |
albuterol aerosol by HFA MDI | Phase 3 | Exercise-induced Bronchospasm | - | - |
Albuterol Spiromax | Phase 3 | Exercise-Induced Bronchoconstriction (EIB) | - | - |
Albuterol Spiromax® | Phase 3 | Asthma | - | - |
Albuterol sulfate (ABS) | Phase 3 | Chronic Obstructive Pulmonary Disease | - | - |
BDP | Phase 3 | Allergic Rhinitis | - | - |
TEV-56248 | Phase 3 | Asthma | - | - |
1.0 mg rasagiline mesylate | Phase 3 | Parkinson's Disease | - | - |
Non-Oral Corticosteroid (non-OCS) Asthma Medication | Phase 3 | Asthma | - | - |
BDP HFA | Phase 3 | Seasonal Allergic Rhinitis | - | - |
Beclomethasone Dipropionate 640 | Phase 3 | Persistent Asthma | - | - |
TV-44749 | Phase 3 | Schizophrenia | - | - |
SD-809 | Phase 3 | Chorea | - | - |
ProAir HFA inhaler | Phase 3 | Asthma | - | - |
BDP Nasal Aerosol | Phase 3 | Allergic Rhinitis | - | - |
DR-103 | Phase 3 | Pregnancy Prevention | - | - |
DR-1021 | Phase 3 | Healthy | - | - |
Trifarotene 0.005 % Topical Cream | Phase 3 | Acne Vulgaris | - | - |
Proventil® HFA | Phase 3 | Asthma | - | - |
Neugranin | Phase 3 | Chemotherapy-induced Neutropenia | - | - |
TV-46000 | Phase 3 | Schizophrenia | - | - |
Reslizumab | Phase 3 | Eosinophilic Asthma | - | - |
40 mg glatiramer acetate | Phase 2 | Amyotrophic Lateral Sclerosis | - | |
Nebulized IVX-0142 | Phase 2 | Asthma | - | - |
Advair Diskus | Phase 2 | Asthma | - | - |
TP-38 | Phase 2 | Recurrent Glioblastoma Multiforme | - | - |
laquinimod 0.3 | Phase 2 | Relapsing Remitting Multiple Sclerosis | - | - |
Tizanidine (sublingual or oral) | Phase 2 | Muscle Spasticity | - | - |
etiprednol dicloacetate | Phase 2 | Crohn's Disease | - | - |
Beclomethasone dipropionate HFA | Phase 2 | Asthma | - | - |
Bronchodilator | Phase 2 | Asthma | - | - |
talampanel | Phase 2 | Dyskinesias | - | - |
TEV-53408 | Phase 2 | Celiac Disease | - | - |
CEP-18770 | Phase 2 | Multiple Myeloma | - | - |
Omacetaxine mepesuccinate | Phase 2 | Chronic Myeloid Leukemia | - | - |
TV-1380 150 mg | Phase 2 | Cocaine Addiction | - | - |
desogestrel/ethinyl estradiol and ethinyl estradiol | Phase 2 | Hemostasis | - | - |
Beclomethasone dipropionate HFA Nasal Aerosol | Phase 2 | Seasonal Allergic Rhinitis | - | - |
91-day Levonorgestrel Oral Contraceptive | Phase 2 | Hemostasis | - | - |
Mometasone furoate | Phase 2 | Seasonal Allergic Rhinitis | - | - |
TV-45070 | Phase 2 | Postherpetic Neuralgia | - | - |
LBR-101 Low Dose | Phase 2 | Episodic Migraine Headache | - | - |
tbo-filgrastim | Phase 2 | Neutropenia | - | - |
TEV-48574 | Phase 2 | Crohn Disease | - | - |
Albuterol HFA-BOI | Phase 2 | Asthma | - | - |
temozolomide(TMZ) 75mg | Phase 2 | Glioblastoma Multiforme | - | - |
TV-1106 | Phase 2 | Growth Hormone Deficiency | - | - |
Delayed Release 6MP or Calcitriol vs. Purinethol | Phase 2 | Crohn's Disease | - | - |
glatiramer acetate 20 mg | Phase 2 | Relapse-Remitting Multiple Sclerosis | - | - |
Armodafinil | Phase 2 | Stroke | - | - |
Prednisolone/Prednisone | Phase 2 | Lupus Nephritis | - | - |
ProAir HFA | Phase 2 | Asthma | - | - |
glatiramer acetate 20 mg, with mitoxantrone | Phase 2 | Relapsing Remitting Multiple Sclerosis | - | - |
Glatiramer Acetate, N-Acetylcysteine | Phase 2 | Relapse Remitting Multiple Sclerosis | - | - |
TEV-56286 | Phase 2 | Multiple System Atrophy | - | - |
ProAir® HFA | Phase 2 | Asthma | - | - |
Tiotropium HFA BAI 4.5 mcg | Phase 2 | COPD | - | - |
Rasagiline | Phase 2 | Dementia | - | - |
Flovent Diskus | Phase 2 | Asthma | - | - |
Immediate release morphine | Phase 2 | Cancer | - | - |
Deutetrabenazine 6 MG | Phase 2 | Dystonia, Primary | - | - |
LBR-101 High Dose | Phase 2 | Chronic Migraine | - | - |
glatiramer acetate with minocycline | Phase 2 | Relapse Remitting Multiple Sclerosis | - | - |
TEV-48574 Dose Regimen A | Phase 2 | Crohn Disease | - | - |
Multiple Sclerosis
2 drugs in this indication
Eye disease (Eylea biosimilar)
1 drug in this indication
asthma
1 drug in this indication
Pediatric patients with Tourette Syndrome
1 drug in this indication
Parkinson's Disease
1 drug in this indication
Amyotrophic Lateral Sclerosis
1 drug in this indication
agitation
1 drug in this indication
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in Teva Pharmaceutical Industries Limited's drug pipeline?→
CatalystAlert tracks 102 drug candidates in Teva Pharmaceutical Industries Limited's (TEVA) pipeline across Phase 3, Phase 2. Its lead program is rasagiline mesylate 1.0 mg (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Teva Pharmaceutical Industries Limited's next FDA catalyst?→
Teva Pharmaceutical Industries Limited's (TEVA) next tracked catalyst is a Offering expected September 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track TEVA biotech catalysts?→
Add TEVA to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Teva Pharmaceutical Industries Limited's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.